MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.19
+0.42 (3.90%)
Jul 21, 2026, 2:22 PM EDT - Market open

MiNK Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5652283788149
Market Cap Growth
-31.13%89.97%-25.39%-58.10%-40.82%-
Enterprise Value
46.3244.2927.9733.6568.73110.42
Last Close Price
11.1911.156.9710.7026.1044.60
PB Ratio
--3.69-1.41-2.05-220.206.28
P/TBV Ratio
-----4.88
Debt / Equity Ratio
--0.36-0.25000
Net Debt / Equity Ratio
0.750.57-0.020.1948.93-1.64
Net Debt / EBITDA Ratio
0.750.66-0.030.150.641.38
Net Debt / FCF Ratio
1.511.38-0.040.211.032.97
Quick Ratio
1.311.030.660.301.552.36
Current Ratio
1.381.060.720.321.612.41
Return on Equity (ROE)
92.67%73.90%57.30%243.36%-239.50%200.76%
Return on Assets (ROA)
-104.19%-126.68%-219.76%-176.15%-100.30%-126.61%
Return on Invested Capital (ROIC)
101.43%112.10%98.62%251.64%835.59%-5325.66%
Return on Capital Employed (ROCE)
-596.85%80346.60%279.10%-2365.28%-190.08%-401.98%
Buyback Yield / Dilution
-14.88%-13.18%-9.82%-2.04%-29.38%-7.95%
Total Shareholder Return
-14.88%-13.18%-9.82%-2.04%-29.38%-7.95%
SEC Filings: 10-K · 10-Q